Insider Shareholders with Direct Ownership of Exagen Inc. (XGN)
This section provides a comprehensive overview of the insiders with direct ownership of Exagen Inc. (XGN). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
EXAGEN INC. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
John Aballi
President and CEO |
634,607 | 33,819 | 600,788 $1.51 Million | 6 |
Feb 29, 2024
Added 1.61%
|
Jeffrey G. Black
Chief Financial Officer |
225,000 | 0 | 252,194 $633,006 | 1 |
Sep 01, 2024
Added 47.15%
|
Kamal Adawi
CFO and Corporate Secretary |
276,000 | 32,251 | 243,749 $611,809 | 9 |
Mar 04, 2024
Reduced 1.41%
|
Mark Hazeltine
Chief Business Officer |
165,434 | 12,729 | 190,205 $477,414 | 6 |
Mar 02, 2023
Reduced 1.89%
|
Fortunato R. Rocca
President and CEO |
125,000 | 4,322 | 120,678 $302,901 | 3 |
Mar 01, 2022
Reduced 3.46%
|
Debra Zack
Chief Medical Officer |
87,500 | 3,241 | 84,259 $211,490 | 3 |
Mar 01, 2022
Reduced 3.7%
|
James L L Tullis
> 10% Shareholder |
0 | 17,500 | 21,348 $53,583 | 8 |
Feb 05, 2021
Reduced 12.32%
|
Wendy S. Johnson
Director |
1,000 | 0 | 1,000 $2,510 | 1 |
Sep 03, 2021
Added 50.0%
|